Cover Image

Aripiprazole Lauroxil, a Novel Injectable Long-Acting Antipsychotic Treatment for Adults with Schizophrenia: A Comprehensive Review

Purpose of Review. This is a comprehensive review of the literature regarding the use of Aripiprazole lauroxil for schizophrenia. This review presents the background, evidence, and indications for using aripiprazole lauroxil to treat schizophrenia in the context of current theories on the developmen...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kunal Maini (Author), Haley Gould (Author), Jessica Hicks (Author), Fatima Iqbal (Author), James Patterson (Author), Amber N. Edinoff (Author), Elyse M. Cornett (Author), Adam M. Kaye (Author), Omar Viswanath (Author), Ivan Urits (Author), Alan D. Kaye (Author)
Format:	Book
Published:	MDPI AG, 2021-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal Dispersion used for initiation of the long-acting antipsychotic aripiprazole lauroxil
by: Marjie L. Hard, et al.
Published: (2019)

Antipsychotic Polypharmacy-Related Cardiovascular Morbidity and Mortality: A Comprehensive Review
by: Amber N. Edinoff, et al.
Published: (2022)

The use of concurrent long-acting injectable antipsychotic therapy with paliperidone palmitate and aripiprazole monohydrate in a patient with schizophrenia
by: Christopher Evernden, BSc, BScPharm, ACPR, et al.
Published: (2021)

Antipsychotic Use in Pregnancy: Patient Mental Health Challenges, Teratogenicity, Pregnancy Complications, and Postnatal Risks
by: Amber N. Edinoff, et al.
Published: (2022)

Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia
by: Michele Wilson, et al.
Published: (2016)

The place of long-acting injectable antipsychotics in the treatment of schizophrenia
by: John M. Kane, et al.
Published: (2023)

Long-acting antipsychotic treatments: focus on women with schizophrenia
by: Sofia Brissos, et al.
Published: (2024)

Long-acting injectable aripiprazole in pregnant women with schizophrenia: a case-series report
by: Blanca Fernández-Abascal, et al.
Published: (2021)

Cenobamate, a Sodium Channel Inhibitor and Positive Allosteric Modulator of GABA<sub>A</sub> Ion Channels, for Partial Onset Seizures in Adults: A Comprehensive Review and Clinical Implications
by: Dustin R. Latimer, et al.
Published: (2021)

Schizophrenia: effects of aripiprazole in metabolic syndrome
by: Deborah Galvão Coelho da Silva, et al.
Published: (2019)

Bremelanotide for Treatment of Female Hypoactive Sexual Desire
by: Amber N. Edinoff, et al.
Published: (2022)

VALTOCO<sup>®</sup> (Diazepam Nasal Spray) for the Acute Treatment of Intermittent Stereotypic Episodes of Frequent Seizure Activity
by: Elyse M. Cornett, et al.
Published: (2021)

Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review
by: Amber N. Edinoff, et al.
Published: (2021)

Identifying dopamine supersensitivity through a randomized controlled study of switching to aripiprazole from other antipsychotic agents in patients with schizophrenia
by: Chia-Hao Ma, et al.
Published: (2022)

Ozanimod to Treat Relapsing Forms of Multiple Sclerosis: A Comprehensive Review of Disease, Drug Efficacy and Side Effects
by: Grace Lassiter, et al.
Published: (2020)

Updated Perspectives on the Neurobiology of Substance Use Disorders Using Neuroimaging
by: Murnane KS, et al.
Published: (2023)

The Possible Application of Ketamine in the Treatment of Depression in Alzheimer's Disease
by: Islam Mohammad Shehata, et al.
Published: (2022)

Paliperidone to Treat Psychotic Disorders
by: Hormazd D. Minwalla, et al.
Published: (2021)

Cost-Effectiveness of Aripiprazole Tablets with Sensor versus Oral Atypical Antipsychotics for the Treatment of Schizophrenia Using a Patient-Level Microsimulation Modeling Approach
by: Chopra AS, et al.
Published: (2023)

Dose-response analysis of aripiprazole in patients with schizophrenia in Taiwan
by: Yun Tien, et al.
Published: (2022)

Istradefylline to Treat Patients with Parkinson's Disease Experiencing "Off" Episodes: A Comprehensive Review
by: Amnon A. Berger, et al.
Published: (2020)

Selective Serotonin Reuptake Inhibitors and Clozapine: Clinically Relevant Interactions and Considerations
by: Amber N. Edinoff, et al.
Published: (2021)

Time to rehospitalization in involuntarily hospitalized individuals suffering from schizophrenia discharged on long-acting injectable antipsychotics or oral antipsychotics
by: Ching-Hua Lin, et al.
Published: (2022)

Benzodiazepines: Uses, Dangers, and Clinical Considerations
by: Amber N. Edinoff, et al.
Published: (2021)

Catatonia: Clinical Overview of the Diagnosis, Treatment, and Clinical Challenges
by: Amber N. Edinoff, et al.
Published: (2021)

Ubrogepant to Treat Acute Migraine in Adults
by: Amber N. Edinoff, et al.
Published: (2021)

Vasodepressor Effects of Adenosine in the Cat are Independent of Cyclooxygenase, Potassium Channels, and Nitric Oxide Pathways
by: Alan David Kaye, et al.
Published: (2019)

Tarlov cysts in a 49-year-old woman presenting with bilateral lower-extremity radiculopathy: A case report
by: Hisham Kassem, et al.
Published: (2020)

Monomethyl Fumarate (MMF, Bafiertam) for the Treatment of Relapsing Forms of Multiple Sclerosis (MS)
by: Amnon A. Berger, et al.
Published: (2021)

Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence
by: Amber N. Edinoff, et al.
Published: (2022)

Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects
by: Amber N. Edinoff, et al.
Published: (2022)

New atypical antipsychotics for schizophrenia: iloperidone
by: Silvio Caccia, et al.
Published: (2010)

Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study
by: Nestor Szerman, et al.
Published: (2020)

Ketamine Evolving Clinical Roles and Potential Effects with Cognitive, Motor and Driving Ability
by: Amber N. Edinoff, et al.
Published: (2023)

Effect of long-acting injectable antipsychotics on hospitalizations and global functioning in schizophrenia: a naturalistic mirror-image study
by: Cristiana Montemagni, et al.
Published: (2022)

Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study
by: Nestor Szerman, et al.
Published: (2020)

Antipsychotics and Mortality in Adult and Geriatric Patients with Schizophrenia
by: Ling-Ling Yeh, et al.
Published: (2023)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
by: Norio Yasui‐Furukori, et al.
Published: (2020)

Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia
by: I. A. Vilyum, et al.
Published: (2018)

Aripiprazole LAI two‐injection start in a 16 year‐old adolescent with schizophrenia
by: Virginio Salvi, et al.
Published: (2022)